DBAN.DEDBAN.DEXETRA
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank79
5Y CAGR-20.4%
Studio
Year-over-Year Change

Price-to-sales ratio

5Y CAGR
-20.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20258.60+108.7%
20244.12+11.8%
20233.68+147.8%
2022-7.71-380.7%
20212.75-89.8%
202026.99+330.2%
20196.28-20.2%
20187.86+34.9%
20175.83+12.5%
20165.18-